These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3085021

  • 1. [Acromegaly. Physiopathological aspects and description of a clinical case].
    Coppola A, Spera C, Buono V, Esposito C, Nasti A.
    Minerva Med; 1986 Mar 17; 77(11):395-401. PubMed ID: 3085021
    [Abstract] [Full Text] [Related]

  • 2. Etiology of pituitary acromegaly.
    Melmed S.
    Endocrinol Metab Clin North Am; 1992 Sep 17; 21(3):539-51. PubMed ID: 1521511
    [Abstract] [Full Text] [Related]

  • 3. [Acromegaly. Recent physiopathological and therapeutic acquisitions].
    Silvestrini F.
    Minerva Med; 1979 Mar 30; 70(15):1065-8. PubMed ID: 108635
    [No Abstract] [Full Text] [Related]

  • 4. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
    Hofland LJ, van Koetsveld PM, van Vroonhoven CC, Stefanko SZ, Lamberts SW.
    J Clin Endocrinol Metab; 1989 Mar 30; 68(3):613-20. PubMed ID: 2493040
    [Abstract] [Full Text] [Related]

  • 5. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Hizuka N, Takano K, Wakabayashi I, Demura H, Ling N.
    J Clin Endocrinol Metab; 1986 Jul 30; 63(1):167-73. PubMed ID: 2872226
    [Abstract] [Full Text] [Related]

  • 6. [Neuroaminergic control of anterior pituitary secretions (author's transl)].
    Mornex R, Jordan D, Pickering A.
    Pathol Biol (Paris); 1976 Oct 30; 24(8):555-74. PubMed ID: 10544
    [Abstract] [Full Text] [Related]

  • 7. Pathophysiology of acromegaly.
    Melmed S, Braunstein GD, Horvath E, Ezrin C, Kovacs K.
    Endocr Rev; 1983 Oct 30; 4(3):271-90. PubMed ID: 6354702
    [Abstract] [Full Text] [Related]

  • 8. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U, Quabbe HJ.
    Acta Neurochir (Wien); 2005 May 30; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [Abstract] [Full Text] [Related]

  • 9. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1978 Dec 30; 47(6):1251-6. PubMed ID: 122426
    [Abstract] [Full Text] [Related]

  • 10. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D, Benlot C, Lagoguey A, Garnier P, Brandi AM, Gautron JP, Legrand JC, Peillon F.
    J Clin Endocrinol Metab; 1989 Mar 30; 68(3):572-7. PubMed ID: 2493037
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic control of anterior pituitary hormone secretion--characterized hypothalamic-hypophysiotropic peptides.
    Grant GF, Vale W.
    Curr Top Exp Endocrinol; 1974 Mar 30; 2():37-72. PubMed ID: 4208407
    [No Abstract] [Full Text] [Related]

  • 12. [Correlations between the secretory function of pituitary tumors and arterial hypertension in acromegaly].
    Zgliczyński S, Słowińska-Srzednicka J, Puciłowska J, Jeske W, Kaniewski M.
    Endokrynol Pol; 1987 Mar 30; 38(5):371-8. PubMed ID: 3454744
    [No Abstract] [Full Text] [Related]

  • 13. Studies on pituitary function in patients with B-cell adenoma.
    Zaccaria M, Giordano G, Vettor R, Ragazzi E, Boscaro M, Federspil G, Scandellari C.
    Horm Metab Res; 1983 Nov 30; 15(11):562-3. PubMed ID: 6317536
    [No Abstract] [Full Text] [Related]

  • 14. Intrasellar pituitary gangliocyto-adenoma presenting with acromegaly: case report.
    Puchner MJ, Herrmann HD.
    Neurosurgery; 1998 May 30; 42(5):1197-9. PubMed ID: 9588573
    [No Abstract] [Full Text] [Related]

  • 15. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
    Candrina R.
    Recenti Prog Med; 1991 Jan 30; 82(1):13-6. PubMed ID: 1902962
    [Abstract] [Full Text] [Related]

  • 16. [Results of the clinical and electroencephalographic studies in patients with acromegaly of different etiologies].
    Pronin VS, Frenkel' GM.
    Probl Endokrinol (Mosk); 1983 Jan 30; 29(2):44-52. PubMed ID: 6407000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan 30; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.